Bastide Le Confort Médical SA (EPA:BLC)
France · Delayed Price · Currency is EUR 23.00
-0.40 (-1.71%)
Aug 3, 2026, 12:34 PM CET
EPA:BLC Income Statement
Financials in millions EUR. Fiscal year is July - June.
Millions EUR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 476.02 | 491.18 | 461.87 | 508.03 | 468.3 | 444.07 | |
Revenue Growth | -3.09% | 6.35% | -9.09% | 8.48% | 5.46% | 16.04% |
Cost of Revenue | 219.41 | 303.15 | 291.28 | 323.43 | 293.95 | 282.98 |
Gross Profit | 256.61 | 188.03 | 170.6 | 184.6 | 174.35 | 161.09 |
Selling, General & Admin | 78.95 | 80.85 | 74.32 | 80.55 | 74.97 | 69.79 |
Depreciation & Amortization Expenses | 57.48 | 59.03 | 55.01 | 58.8 | 56.05 | 50.8 |
Other Operating Expenses | 13.32 | 21.13 | 34.61 | 22.09 | 23.2 | 17.49 |
Total Operating Expenses | 149.75 | 161.01 | 163.94 | 161.44 | 154.22 | 138.07 |
Operating Income | 106.86 | 27.02 | 6.66 | 23.16 | 20.13 | 23.02 |
Interest Income | 0.03 | 0.03 | 0 | 0.04 | 0.01 | 0 |
Interest Expense | -27.3 | -30.84 | -26.88 | -16.59 | -10.2 | -8.91 |
Other Non-Operating Income (Expense) | 0.12 | 2.19 | 5.3 | 2.66 | -1.33 | 0.77 |
Total Non-Operating Income (Expense) | -27.16 | -28.63 | -21.58 | -13.89 | -11.53 | -8.13 |
Pretax Income | 11.57 | 10.54 | 13.11 | 22.77 | 21.02 | 20.17 |
Provision for Income Taxes | 3.95 | 6.49 | 6.61 | 5.96 | 5.93 | 5.82 |
Net Income | 7.73 | 4.05 | 6.51 | 16.81 | 15.09 | 14.35 |
Minority Interest in Earnings | 0.55 | 1.03 | 2.11 | 0.74 | 0.65 | 0.9 |
Earnings From Discontinued Operations | 22.29 | -2.49 | -5.3 | -4.02 | -0.76 | 0 |
Net Income to Common | 29.45 | 0.53 | -0.9 | 12.05 | 13.68 | 13.45 |
Net Income Growth | 5477.08% | - | - | -11.94% | 1.70% | 15.97% |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 7 | 7 |
Shares Change | -0.02% | -0.04% | 0.04% | 7.66% | 0.22% | 0.03% |
EPS (Basic) | 3.94 | 0.07 | -0.12 | 1.62 | 1.86 | 1.83 |
EPS (Diluted) | 3.86 | 0.07 | -0.12 | 1.52 | 1.86 | 1.83 |
EPS Growth | 5414.29% | - | - | -18.28% | 1.64% | 15.82% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | 57.38 | 41.74 | 24.46 | 52.05 | 3.59 | 27.85 |
Free Cash Flow Growth | 37.46% | 70.68% | -53.01% | 1351.37% | -87.12% | 269.46% |
Free Cash Flow Per Share | 7.23 | 5.26 | 3.08 | 6.56 | 0.49 | 3.79 |
Dividends Per Share | - | - | - | - | - | 0.270 |
Dividend Growth | - | - | - | - | - | 0% |
Gross Margin | 53.91% | 38.28% | 36.94% | 36.34% | 37.23% | 36.28% |
Operating Margin | 22.45% | 5.50% | 1.44% | 4.56% | 4.30% | 5.18% |
Profit Margin | 1.62% | 0.82% | 1.41% | 3.31% | 3.22% | 3.23% |
FCF Margin | 12.05% | 8.50% | 5.30% | 10.24% | 0.77% | 6.27% |
EBITDA | 165.94 | 87.66 | 61.85 | 81.92 | 79.55 | 73.82 |
EBITDA Margin | 34.86% | 17.85% | 13.39% | 16.13% | 16.99% | 16.62% |
EBIT | 106.86 | 27.02 | 6.66 | 23.16 | 20.13 | 23.02 |
EBIT Margin | 22.45% | 5.50% | 1.44% | 4.56% | 4.30% | 5.18% |
Effective Tax Rate | 34.09% | 61.59% | 50.40% | 26.18% | 28.21% | 28.87% |